Sign in

CIK 0001447028

  • Non-accelerated filer
  • Smaller reporting company

Arbutus Biopharma Corp

Sign in to watch
Ticker
ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980597776
Phone
+1 604-419-3200
Business address
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
Former names
TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 16 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-12 Lo Andrew 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2018-01-12 Roivant Sciences Ltd. 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2018-01-12 Machado Patrick 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2018-01-12 VIKING GLOBAL INVESTORS LP 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2018-01-12 VIKING GLOBAL PERFORMANCE LLC 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2018-01-12 QVT Associates GP LLC Director Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2017-10-16 Dexxon Holdings Ltd. 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 SVF Investments (UK) Ltd 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 Lo Andrew 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 Roivant Sciences Ltd. 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 Machado Patrick 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 VIKING GLOBAL INVESTORS LP 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 VIKING GLOBAL PERFORMANCE LLC 10% owner Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-16 QVT Associates GP LLC Director Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50.0M 500,000
2017-10-03 Sofia Michael J. Chief Scientific Officer Sale −10,000 $8.00 $80K 1,553,403
2017-08-15 Sofia Michael J. Chief Scientific Officer Sale −10,000 $3.75 $38K 191,412
2017-08-15 Sofia Michael J. Chief Scientific Officer Sale −20,000 $3.68 $74K 171,412
2017-06-21 MANCHESTER KEITH S Director Grant or award · Stock Option (right to buy) +22,000 22,000
2017-06-21 Ramaswamy Vivek Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2017-06-21 KARBE FRANK Director Grant or award · Stock Option (Right to Buy) +22,000 22,000

Page 10 of 12 · 239 trades